Application 021065
- Type
- NDA
- Sponsor
- APIL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FEMHRT | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL | 0.0025MG;0.5MG | No | No |
| 002 | FEMHRT | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL | 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0430-0145 | femhrt | norethindrone acetate/ethinyl estradiol | Allergan, Inc. | NDA | Current |
| 0430-0145 | femhrt | norethindrone acetate/ethinyl estradiol | Allergan, Inc. | NDA | Current |
| 52544-236 | Jevantique Lo | Norethindrone Acetate and Ethinyl Estradiol | Actavis Pharma, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 74336 | SUPPL | 2023-05-22 |
| 74335 | SUPPL | 2023-05-22 |
| 74319 | SUPPL | 2023-05-19 |
| 74318 | SUPPL | 2023-05-19 |
| 50277 | SUPPL | 2017-11-02 |
| 35993 | SUPPL | 2014-01-10 |
| 4187 | SUPPL | 2014-01-10 |
| 26612 | SUPPL | 2005-01-21 |
| 14269 | SUPPL | 2005-01-21 |
| 35992 | SUPPL | 2004-01-22 |
| 26611 | SUPPL | 2004-01-22 |
| 41918 | ORIG | 1999-10-15 |
| 23065 | ORIG | 1999-10-15 |
| 14268 | ORIG | 1999-10-15 |
| 4186 | ORIG | 1999-10-15 |